RESEARCH
Oncology Conference Highlights
Check out our selection of oncology materials from various Oncology conferences.
The American Society of Clinical Oncology (ASCO), and the European Society for Medical Oncology (ESMO), have for many years been the predominant societies in oncology research. Their meetings each year are a platform for research exchange and as the leading professional organisations for medical oncology, with thousands of combined members, they represent oncology professionals from over all over the world.
At Karger we want to transfer the knowledge gained at these congresses through easy to access materials.
On this page you will find a variety of materials such as summary sheets, videos, and podcasts, that we hope will help you to summarise these in-depth meetings in a concise way.
ASCO Annual Meeting 2022
The 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO) was held in Chicago, IL on June 3–7, 2022 with both in-person and online attendance.
The theme of the meeting was “Advancing Equitable Cancer Care Through Innovation”, and it included over 200 sessions revealing novel findings in cancer research, therapy, and care. Advances in breast cancer research and therapeutics were the conference topics attracting broadest interest.
Breast Cancer Highlights
This sheet summarizes all the key findings from the 2022 meeting.
Authored by Dr Zoya Marinova (United States), with contributions from Dr Vinícius Knackfuss Gonçalves (Brazil) and Prof. Bernardo L Rapoport (South Africa).
Expert Discussion Breast Cancer
An expert discussion on PALOMA-2 OS data presented at ASCO 2022 with Marija Balic, Kerstin Wimmer, Christoph Suppan, Tajana Silovski and Christine Brunner.
Conference Commentary Breast Cancer
In this article, the latest advancements presented at the ASCO conference regarding metastatic breast are reviewed.
Breast Cancer - Fast Facts Oncology Podcast
Fast Facts Oncology is a five-part special that focuses on breast cancer, specifically looking at issues pertinent to low- and middle-income countries (LMICs). We are joined experts Dr Vinicius Goncalves, Dr Shaheenah Dawood, Dr Omar Hamid and Adeda Steenkamp from the Cancer Association of South Africa.
Listen the series Podcast Fast Facts Oncology - S1 - Karger Publishers and on all major streaming platforms.
Breast Cancer - An Interview with Abeda Steenkamp
For Breast Cancer Awareness Month in October we turned to the Cancer Association of South Africa (CANSA) to learn more about their mission and vision.
We spoke with Abeda Steenkamp about stigma and taboos surrounding cancer that she sees in South Africa. Furthermore, she shares her own experiences as a breast cancer patient, discusses the important role of education and support, and gives an insight into her work and tasks as a Service Coordinator for CANSA.
ESMO Annual Meeting 2022 – Breast Cancer and Colorectal Cancer
- Breast Cancer Video Interviews
- Breast Cancer Podcasts
- Breast Cancer Expert Discussion
- Colorectal Cancer highlights
- Colorectal Cancer Video Interviews
- Colorectal Cancer Podcast
- Colorectal Cancer Supplement Issue
Colorectal Cancer Highlights
This sheet summarizes all the key findings from the 2022 ESMO annual meeting.
Authored by Dr Guy Regnard (South Africa). Reviewed by Prof. Dr Dirk Arnold (Germany), Dr Rosario Pitargue (Philippines), Dr Maria Belen E. Tamayo (Philippines).
Dr. Hope Rugo – ESMO 2022 – Exploring the Latest Trial Data & Advances in Breast Cancer Treatments
Welcome to the third episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer we speak with Dr Hope Rugo, Director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr Rugo summarizes the TROPICS02 trial that she presented at this year's conference. We also discuss how data presented from the METEORA and ICON trials add to clinical understandings of immunotherapy response. Coverage is also provided to the ADAPT trial. Finally, we discuss how these clinical improvements in response and progression free survival (PFS) translate to the patient experience.
Dr. Chetan Deshmukh – ESMO 2022 – The Latest Updates in Colorectal Cancer
Welcome to the first episode in a three-part special live from ESMO 2022. In this episode focused on colorectal cancer, we speak with Dr Chetan Deshmukh, a practicing medical oncologist from Pune, India. Dr Deshmukh discusses the results from the CARIO5 study which have been presented at the congress. He also shares with us his thoughts on the promise of novel immunotherapeutics and targeted therapies in CRC management and provides his perspective on disparities in drug access in low-middle income countries.
Dr. Shaheenah Dawood – ESMO 2022 – Clinical Trial Updates in Breast Cancer Management
Welcome to the second episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer, we speak with Dr Shaheenah Dawood, a practicing medical oncologist from Dubai, United Arab Emirates. Dr Dawood discusses the MONARCH3 trial – its background, recent findings and how it differs from the MONARCHER trial. Coverage is also given to the presentations on oral selective estrogen receptor downregulators (SERDs) as a treatment option for breast cancer patients.
Karger's Choice
Article Collection in Breast Cancer
-
HER2-Low Breast Cancer: Where Are We?
Molinelli C. · Jacobs F. · Marchiò C. · Pitto F. · Cosso M. · Spinaci S. · de Azambuja E. · Schettini F. · Agostinetto E. · Lambertini M.
Breast Care 2022;17:533–544 (DOI:10.1159/000527391) -
Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates
Rakha E.A. · Chmielik E. · Schmitt F.C. · Tan P.H. · Quinn C.M. · Gallagy G.
Pathobiology 2022;89:263–277 (DOI:10.1159/000525092) -
Unusual Patterns of HER2 Expression in Breast Cancer: Insights and Perspectives
Grassini D. · Cascardi E. · Sarotto I. · Annaratone L. · Sapino A. · Berrino E. · Marchiò C.
Pathobiology 2022;89:278–296 (DOI:10.1159/000524227) -
Receptor Status after Neoadjuvant Therapy of Breast Cancer: Significance and Implications
Shaaban A.M. · Provenzano E.
Pathobiology 2022;89:297–308 (DOI:10.1159/000521880) -
Incidence of HPVs, EBV, and MMTV-Like Virus in Breast Cancer in Qatar
Gupta I. · Al-Sarraf R. · Farghaly H. · Vranic S. · Sultan A.A. · Al-Thawadi H. · Al Moustafa A.-E. · Al-Farsi H.F.
Intervirology 2022;65:188–194 (DOI:10.1159/000525277) -
Optimal Systemic Treatment for Early Triple-Negative Breast Cancer
Furlanetto J. · Loibl S.
Breast Care 2020;15:217–226 (DOI:10.1159/000508759) -
St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer
Thomssen C. · Balic M. · Harbeck N. · Gnant M.
Breast Care 2021;16:135–143 (DOI:10.1159/000516114) -
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022
Thill M. · Lüftner D. · Kolberg-Liedtke C. · Albert U.-S. · Banys-Paluchowski M. · Bauerfeind I. · Blohmer J.-U. · Budach W. · Dall P. · Fallenberg E.M. · Fasching P.A. · Fehm T. · Friedrich M. · Gerber B. · Gluz O. · Harbeck N. · Heil J. · Huober J. · Jackisch C. · Kreipe H.-H. · Krug D. · Kühn T. · Kümmel S. · Loibl S. · Lux M. · Maass N. · Mundhenke C. · Nitz U. · Park-Simon T.-W. · Reimer T. · Rhiem K. · Rody A. · Schmidt M. · Schneeweiss A. · Schütz F. · Sinn H.-P. · Solbach C. · Solomayer E.-F. · Stickeler E. · Thomssen C. · Untch M. · Witzel I. · Wöckel A. · Müller V. · Janni W. · Ditsch N.
(DOI:10.1159/000524789) -
Check Your Breasts – Save Your Life: An Interview with Sonja Dinner (The DEAR Foundation)
The Waiting Room - Interviews -
Breast Cancer Genes and Hereditary Breast and Ovarian Cancer
The Waiting Room - Knowledge Transfer
Article Collection in Colorectal Cancer
-
Solitary Cardiac Metastasis from Colorectal Cancer: A Case Report
Numata K. · Urata N. · Nakayama Y. · Ju M. · Tanaka A. · Nakayama H. · Yamanaka K. · Hatori S. · Matsubara O. · Rino Y. · Tani K.
Case Rep Oncol 2022;15:798–803 (DOI:10.1159/000526549) -
Outcomes of Patients with Left-Sided Obstructive Colorectal Cancer: Comparison between Self-Expandable Metallic Stent and Other Treatment Methods
Kondo A. · Kumamoto K. · Kobara H. · Nagahara T. · Wato M. · Shibatoge M. · Minato T. · Masaki T. · Okano K. · on behalf of the Kagawa Gastroenterology Forum
Dig Surg 2022;39:117–124 (DOI:10.1159/000524645) -
Identification of Biomarkers Associated with the Prognoses of Colorectal Cancer Patients
Fang Y. · Zhan X.
Digestion (DOI:10.1159/000528084) -
Colorectal Cancer Prognosis: The Impact of Signet Ring Cell
Bademci R. · Bollo J. · Martinez M.C. · Hernadez M.P. · Targarona E.M.
Gastrointest Tumors 2019;6:57–63 (DOI:10.1159/000501454) -
Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and Surveillance
Wang Z.-H. · Fang J.-Y.
Gastrointest Tumors 2014;1:146-154 (DOI:10.1159/000365309) -
Evaluation of a Phone Call Reminder Strategy in the Surveillance of Patients with Gastric Precancerous Lesions Lost to Follow-Up
Chapelle N. · Jirka I. · Péron M. · Quénéhervé L. · Cauchin E. · Touchefeu Y. · Coron E. · Mosnier J.-F. · Matysiak-Budnik T.
Gastrointest Tumors 2020;7:110–116 (DOI:10.1159/000508873) -
9 Frequently Asked Questions about Colonoscopy
The Waiting Room - Tell Me About ... -
Inflammatory Bowel Disease: Current and New Regenerative Medicine Treatment Strategies
The Waiting Room - Knowledge Transfer
